Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| FELIQS | 2025 | Series A | $8.4M | Kurume |
| Thinker | 2025 | Series Unknown | $3.5M | Tokyo |
| Global Vascular | 2025 | Series B | $19.3M | Tokyo |
| Phytolipid Technologies | 2025 | Seed | $1.5M | Yokohama |
| Reborna Biosciences | 2025 | Series Unknown | $5.3M | Fujisawa |
| Iwaya Giken | 2025 | Series Unknown | Undisclosed | Ebetsu |
| Modalis Therapeutics | 2025 | Post Ipo Equity | Undisclosed | Tokyo |
| Letara | 2025 | Seed | Undisclosed | Sapporo |
| Ugo | 2025 | Series Unknown | Undisclosed | Higashi-shinagawa |
| Towing | 2025 | Series B | $13.5M | Nagoya |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 176 | FELIQS | Series A | $8.4M | Kurume, Japan |
| 177 | Thinker | Series Unknown | $3.5M | Tokyo, Japan |
| 178 | Global Vascular | Series B | $19.3M | Tokyo, Japan |
| 179 | Phytolipid Technologies | Seed | $1.5M | Yokohama, Japan |
| 180 | Reborna Biosciences | Series Unknown | $5.3M | Fujisawa, Japan |
| 181 | Iwaya Giken | Series Unknown | Undisclosed | Ebetsu, Japan |
| 182 | Modalis Therapeutics | Post Ipo Equity | Undisclosed | Tokyo, Japan |
| 183 | Letara | Seed | Undisclosed | Sapporo, Japan |
| 184 | Ugo | Series Unknown | Undisclosed | Higashi-shinagawa, Japan |
| 185 | Towing | Series B | $13.5M | Nagoya, Japan |
FELIQS is a research-based start-up specializing in pharmaceutical sciences.
Thinker is a technology company that specializes in the sales of proximity sensors and offers proposed solutions using these products.
Global Vascular designs and develops a drug-eluting stent delivery system using nanotechnology for lower limb artery disease.
Phytolipid Technologies specializes in the research and production of lipids in plants and algae and is an expert in lipid analysis.
Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.
Iwaya Giken manufactures and sells gas balloons, airtight cabins, and other space-travel equipment.
Modalis is a biotech company that develops therapeutics using CRISPR based technology.
Letara is an aerospace component manufacturing company that produces hybrid propulsion engines for small spacecraft.
Ugo is a robotics solutions company that creates sustainable work environments by combining humans and robots.
Towing is an agricultural company that provides farming, manufacturing, and recycling services.
obniz is an IT company that offers curated IoT systems to control sensors, actuators, and machines directly through the cloud.
Japan Culture and Technology is a travel booking platform that offers technology to make tourism seamless.
Utaite is an operator of an entertainment platform that focuses on planning, production, and development of entertainment content.
Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.
ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology.
Manabie is an education technology start-up company on a mission to provide a new style of online and offline merged learning.
M & A Cloud is a matching platform for small and medium venture companies.
10X is a IT company that develops digital platform for chain stores such as supermarkets and drugstores to develop their business.
Asusola is a renewable energy developer that specializes in the installation and operation of wind and solar energy projects.
Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions.
CADDi is an AI Data platform that offers drawings and supply chain data with a specialization in procurement intelligence.
Instalimb specializes in developing low-cost 3D printed prosthetics using 3D-CAD, 3D printing and AI technology.
Emium creates an infrastructure that will be a driving force in dental care and dental technology.
Style Port is an Internet VR platform that helps real estate agents advertise and enables users to visualize the interior of a property.
RegCell is a novel therapeutics company that offers medical treatment to patients using regulatory T cells.
Mitsubishi UFJ Capital has invested in 443 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Mitsubishi UFJ Capital's top investment sectors include Manufacturing, Health Care, Software, Medical, Sales. The firm invests across 62 different industry categories.
Among tracked funding rounds, Utaite received $51.9M in a Series B round. Mitsubishi UFJ Capital's total known invested capital is $2.0B.
Mitsubishi UFJ Capital's average investment size is $7.5M across its portfolio of 443 companies.
Recent Mitsubishi UFJ Capital portfolio additions include FELIQS, Thinker, Global Vascular, Phytolipid Technologies, Reborna Biosciences. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors